These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17979658)

  • 61. Application of small RNA technology for improved control of parasitic helminths.
    Britton C; Winter AD; Marks ND; Gu H; McNeilly TN; Gillan V; Devaney E
    Vet Parasitol; 2015 Aug; 212(1-2):47-53. PubMed ID: 26095949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Specific and potent RNAi in the nucleus of human cells.
    Robb GB; Brown KM; Khurana J; Rana TM
    Nat Struct Mol Biol; 2005 Feb; 12(2):133-7. PubMed ID: 15643423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Generation of secondary small interfering RNA in cell-autonomous and non-cell autonomous RNA silencing in tobacco.
    Shimamura K; Oka S; Shimotori Y; Ohmori T; Kodama H
    Plant Mol Biol; 2007 Apr; 63(6):803-13. PubMed ID: 17225952
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.
    Shukla S; Sumaria CS; Pradeepkumar PI
    ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biogenesis and function of endogenous and exogenous siRNAs.
    Snead NM; Rossi JJ
    Wiley Interdiscip Rev RNA; 2010; 1(1):117-31. PubMed ID: 21956909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.
    von Eije KJ; Berkhout B
    Antivir Chem Chemother; 2009; 19(6):221-33. PubMed ID: 19641231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RNA interference in neuroscience: progress and challenges.
    Miller VM; Paulson HL; Gonzalez-Alegre P
    Cell Mol Neurobiol; 2005 Dec; 25(8):1195-207. PubMed ID: 16388332
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics.
    Ning B; Yu D; Yu AM
    Biochem Pharmacol; 2019 Nov; 169():113638. PubMed ID: 31518552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.
    Jin Q; Wu J; Wu Y; Li H; Finel M; Wang D; Ge G
    Acta Pharm Sin B; 2022 Mar; 12(3):1068-1099. PubMed ID: 35530147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
    Raju B; Choudhary S; Narendra G; Verma H; Silakari O
    Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inducible and reversible breaching of the blood brain barrier by RNAi.
    Rossi JJ
    EMBO Mol Med; 2011 Apr; 3(4):186-8. PubMed ID: 21394916
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes.
    Jeong H
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):689-99. PubMed ID: 20367533
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
    Cronin JM; Yu AM
    Drug Metab Dispos; 2023 Jun; 51(6):685-699. PubMed ID: 36948592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.